Dexcom (DXCM) Retained Earnings (2010 - 2026)
Dexcom (DXCM) posted quarterly Retained Earnings of $2.9 billion for Q2 2026, up 53.1% year-over-year from $1.9 billion in Q2 2025, and up 9.46% quarter-over-quarter from $2.6 billion in Q1 2026.
Dexcom (DXCM) Retained Earnings (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Retained Earnings for 17 consecutive years, with $2.9 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Retained Earnings rose 53.1% year-over-year to $2.9 billion; the TTM figure through Jun 2026 stood at $2.9 billion (up 53.1% YoY), while the FY2025 annual figure was $2.4 billion, up 52.35% from the prior year.
- Retained Earnings grew to $2.9 billion in Q2 2026 per DXCM's latest filing, from $2.6 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $2.9 billion in Q2 2026 and bottomed at $236.0 million in Q1 2022.
- Historically, Retained Earnings has averaged $1.3 billion across 5 years, with a median of $1.2 billion in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 1486.07% — and 2025, when it surged 43.58%.
- Dexcom's Retained Earnings stood at $479.9 million in 2022, then jumped by 112.84% to $1.0 billion in 2023, then soared by 56.41% to $1.6 billion in 2024, then jumped by 52.35% to $2.4 billion in 2025, then climbed by 18.43% to $2.9 billion in 2026.
- Business Quant data shows DXCM's Retained Earnings at $2.9 billion in Q2 2026, $2.6 billion in Q1 2026, and $2.4 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 11.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Bn |
| Mar 31, 2026 | 2.63 Bn |
| Dec 31, 2025 | 2.43 Bn |
| Sep 30, 2025 | 2.17 Bn |
| Jun 30, 2025 | 83.60 Mn |
| Mar 31, 2025 | 1.70 Bn |
| Dec 31, 2024 | -8.00 Mn |
| Sep 30, 2024 | 1.45 Bn |
| Jun 30, 2024 | 1.31 Bn |
| Mar 31, 2024 | 1.17 Bn |
| Dec 31, 2023 | 1.02 Bn |
| Sep 30, 2023 | -35.60 Mn |
| Jun 30, 2023 | 644.40 Mn |
| Mar 31, 2023 | -6.50 Mn |
| Dec 31, 2022 | -11.60 Mn |
| Sep 30, 2022 | 388.10 Mn |
| Jun 30, 2022 | -23.00 Mn |
| Mar 31, 2022 | 236.00 Mn |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | -28.00 Mn |